130 related articles for article (PubMed ID: 26132704)
1. Evaluation of the Antitumor Efficacy of RNAi-Mediated Inhibition of CDC20 and Heparanase in an Orthotopic Liver Tumor Model.
Liu M; Zhang Y; Liao Y; Chen Y; Pan Y; Tian H; Zhan Y; Liu D
Cancer Biother Radiopharm; 2015 Aug; 30(6):233-9. PubMed ID: 26132704
[TBL] [Abstract][Full Text] [Related]
2. Increased CDC20 expression is associated with development and progression of hepatocellular carcinoma.
Li J; Gao JZ; Du JL; Huang ZX; Wei LX
Int J Oncol; 2014 Oct; 45(4):1547-55. PubMed ID: 25069850
[TBL] [Abstract][Full Text] [Related]
3. PI-88 inhibits postoperative recurrence of hepatocellular carcinoma via disrupting the surge of heparanase after liver resection.
Liao BY; Wang Z; Hu J; Liu WF; Shen ZZ; Zhang X; Yu L; Fan J; Zhou J
Tumour Biol; 2016 Mar; 37(3):2987-98. PubMed ID: 26415733
[TBL] [Abstract][Full Text] [Related]
4. Heparanase is involved in proliferation and invasion of ovarian cancer cells.
Zheng H; Ruan J; Zhao P; Chen S; Pan L; Liu J
Cancer Biomark; 2015; 15(5):525-34. PubMed ID: 25586097
[TBL] [Abstract][Full Text] [Related]
5. [Heparanase promotes trans-endothelial migration of hepatocarcinoma cells by inducing apoptosis of microvascular endothelial cells].
Chen X; Ye R; Dai D; Wu Y; Yu Y; Cheng B
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Aug; 40(8):1065-1071. PubMed ID: 32895190
[TBL] [Abstract][Full Text] [Related]
6. APC
Shi M; Dai WQ; Jia RR; Zhang QH; Wei J; Wang YG; Xiang SH; Liu B; Xu L
Cancer Lett; 2021 Jan; 496():144-155. PubMed ID: 33039559
[TBL] [Abstract][Full Text] [Related]
7. Synthesized multiple antigenic polypeptide vaccine based on B-cell epitopes of human heparanase could elicit a potent antimetastatic effect on human hepatocellular carcinoma in vivo.
Zhang J; Yang JM; Wang HJ; Ru GQ; Fan DM
PLoS One; 2013; 8(1):e52940. PubMed ID: 23308126
[TBL] [Abstract][Full Text] [Related]
8. CDC20 regulates the cell proliferation and radiosensitivity of P53 mutant HCC cells through the Bcl-2/Bax pathway.
Zhao S; Zhang Y; Lu X; Ding H; Han B; Song X; Miao H; Cui X; Wei S; Liu W; Chen S; Wang J
Int J Biol Sci; 2021; 17(13):3608-3621. PubMed ID: 34512169
[No Abstract] [Full Text] [Related]
9. Silencing of CDC20 suppresses metastatic castration-resistant prostate cancer growth and enhances chemosensitivity to docetaxel.
Li K; Mao Y; Lu L; Hu C; Wang D; Si-Tu J; Lu M; Peng S; Qiu J; Gao X
Int J Oncol; 2016 Oct; 49(4):1679-85. PubMed ID: 27633058
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of heparanase by RNA interference inhibits invasion and tumorigenesis of hepatocellular cancer cells in vitro and in vivo.
Xiong Z; Lü MH; Fan YH; Cao YL; Hu CJ; Wu YY; Wang SM; Luo G; Fang DC; Li C; Yang SM
Int J Oncol; 2012 May; 40(5):1601-9. PubMed ID: 22267022
[TBL] [Abstract][Full Text] [Related]
11. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL
Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658
[TBL] [Abstract][Full Text] [Related]
12. Interleukin‑17A and heparanase promote angiogenesis and cell proliferation and invasion in cervical cancer.
Lv Q; Wu K; Liu F; Wu W; Chen Y; Zhang W
Int J Oncol; 2018 Oct; 53(4):1809-1817. PubMed ID: 30066843
[TBL] [Abstract][Full Text] [Related]
13. Multiple antigenic polypeptide composed of heparanase B‑cell epitopes shrinks human hepatocellular carcinoma in mice.
Zhang J; Yang J; Cai Y; Jin N; Wang H; Yu T
Oncol Rep; 2015 Mar; 33(3):1248-56. PubMed ID: 25522727
[TBL] [Abstract][Full Text] [Related]
14. Effects of AFP gene silencing on apoptosis and proliferation of a hepatocellular carcinoma cell line.
Zhang L; He T; Cui H; Wang Y; Huang C; Han F
Discov Med; 2012 Aug; 14(75):115-24. PubMed ID: 22935208
[TBL] [Abstract][Full Text] [Related]
15. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting tumor growth by targeting liposomally encapsulated CDC20siRNA to tumor vasculature: therapeutic RNA interference.
Majumder P; Bhunia S; Bhattacharyya J; Chaudhuri A
J Control Release; 2014 Apr; 180():100-8. PubMed ID: 24556418
[TBL] [Abstract][Full Text] [Related]
17. TPX2 siRNA regulates growth and invasion of esophageal cancer cells.
Liu HC; Zhang GH; Liu YH; Wang P; Ma JF; Su LS; Li SL; Zhang L; Liu JW
Biomed Pharmacother; 2014 Sep; 68(7):833-9. PubMed ID: 25239289
[TBL] [Abstract][Full Text] [Related]
18. GTSE1, CDC20, PCNA, and MCM6 Synergistically Affect Regulations in Cell Cycle and Indicate Poor Prognosis in Liver Cancer.
Zheng Y; Shi Y; Yu S; Han Y; Kang K; Xu H; Gu H; Sang X; Chen Y; Wang J
Anal Cell Pathol (Amst); 2019; 2019():1038069. PubMed ID: 32082966
[TBL] [Abstract][Full Text] [Related]
19. Diosgenin exerts its tumor suppressive function via inhibition of Cdc20 in osteosarcoma cells.
Long C; Chen J; Zhou H; Jiang T; Fang X; Hou D; Liu P; Duan H
Cell Cycle; 2019 Feb; 18(3):346-358. PubMed ID: 30640578
[TBL] [Abstract][Full Text] [Related]
20. Expressions of heparanase and upstream stimulatory factor in hepatocellular carcinoma.
Chen B; Chen XP; Wu MS; Cui W; Zhong M
Eur J Med Res; 2014 Aug; 19(1):45. PubMed ID: 25149140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
